School of Medicine researchers believe an old cancer drug may treat a devastating blood vessel disease. A new clinical trial is evaluating the drug’s potential for use in patients with retinal vasculopathy with cerebral leukodystrophy.
School of Medicine researchers have found that the pathways through which various types of brain cells are damaged by Alzheimer’s disease varies, depending on the genes involved. The findings are published in the journal Genome Medicine.
Cheri LeBlanc, MD, has been appointed executive director of Habif Health & Wellness Center. LeBlanc had served as interim director after the departure of Alan Glass, MD, and had served since 2013 as director of student health and wellness.
North America had more to offer soccer’s international governing body than its competition, said Patrick Rishe, a university sports business expert. As a result, the “United Bid” of the U.S., Canada and Mexico was awarded the 2026 World Cup.
Our daily lives revolve around the internet, whether it’s personal contact, news or the sharing of political views. As such, there remains significant work to do so the internet can deal with the real challenges it faces, internet privacy expert Neil Richards said.
You have received this e-mail because you expressed interest in receiving updates from wustl.edu, the Record and its related products by e-mail. Thanks for your subscription. If you do not want to receive the Record via e-mail, you may unsubscribe. Got this as a forward? Sign up to receive our future e-mails.
Sandor Kovacs, MD, PhD, professor of medicine at the School of Medicine, recently received an honorary degree from Lund University in Sweden.